Over 95% of all approved biologics and 90% of all vaccines are cold chain dependent. The World Health Organization estimates that up to 50% of vaccines are lost annually due to cold chain failures. To meet new demands and reduce losses, modern cold chains should be supported by robust and reliable freezing solutions.

This trend has been further confirmed by the new Annex 1 from the EU GMP, which highlights freezing and thawing operations as critical steps, and calls for appropriate systems that can manage and reduce risks.

In this webinar, three experts in cold chain management will walk through the advantages of end-to-end platforms for bulk drug substance management.

They’ll discuss new solutions that enhance scalability for large volumes, along with an automated filling solution that reduces product loss and improves process viability. Join to learn how the next generation of cold chain management is both fully scalable and automated.

In this webinar you’ll learn:

• How to reduce product loss and improve process viability in your cold chain management
• Improving scalability at large volumes
• Advantages of an end-to-end fully qualified platform approach in cold chain management

• Bioprocessing & Biomanufacturing
• Processing engineering & Supply Chain
• Quality controlCDMOs